NICE Publishes Briefing on Saluda's Evoke Closed-Loop Spinal Cord Stimulation (SCS) System ARTARMON, Australia, Dec. 22, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") announced today that the UK's National Institute for Health and Care Excellence (NICE) issued a Medtech Innovation Briefing (MIB) titled "Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain." The MIB states Evoke would be used as a replacement option or alternative to current open-loop (fixed-output) spinal cord stimulation therapy in people with leg and back pain. The Evoke Closed-Loop SCS System is the first and only SCS technology designed to measure the spinal cord's response to stimulation and make real-time, automatic adjustments intended to remain in the therapeutic range and provide long-term pain relief.